Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 07-Feb-24 4:59 PM View:  | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Feb-24 | Grant | 33,700 | -- | -- | 133% 25.38K to 59.08K | |
| 07-Jun-23 9:34 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,357 | $37.87 | $51,382.80 | (6%) 22.25K to 20.89K | |
| 07-Jun-23 9:34 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 1,301 | $38.99 | $50,727.30 | (6%) 23.55K to 22.25K | |
| 08-Jun-22 7:46 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-22 | Grant | 9,900 | -- | -- | 73% 13.65K to 23.55K | |
| 08-Jun-22 7:46 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-22 | Market Sale (Planned) | 4,649 | $59.51 | $276,662.00 | (25%) 18.3K to 13.65K | (3%) |
| 08-Jun-22 7:46 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-22 | Market Sale | 3,969 | $61.37 | $243,593.00 | (18%) 22.27K to 18.3K | < 1% |
| 23-Mar-22 4:37 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 21-Mar-22 | Option Exercise | 7,253 | $42.67 | $309,462.00 | 33% 22.27K to 29.52K | |
| 23-Mar-22 4:37 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 21-Mar-22 | Planned Option Sale | 7,253 | $72.67 | $527,076.00 | (25%) 29.52K to 22.27K | |
| 01-Mar-22 5:43 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 25-Feb-22 | Option Exercise | 2,050 | $38.35 | $78,617.50 | 9% 22.27K to 24.32K | |
| 01-Mar-22 5:43 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 25-Feb-22 | Planned Option Sale | 2,050 | $67.02 | $137,390.00 | (8%) 24.32K to 22.27K | |
| 01-Mar-22 5:43 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Feb-22 | Option Exercise | 10 | $38.35 | $383.50 | < 1% 22.27K to 22.28K | |
| 01-Mar-22 5:43 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Feb-22 | Planned Option Sale | 10 | $65.00 | $650.00 | (< 1%) 22.28K to 22.27K | |
| 14-Feb-22 10:00 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 10-Feb-22 | Option Exercise | 800 | $38.35 | $30,680.00 | 4% 22.27K to 23.07K | |
| 14-Feb-22 10:00 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 10-Feb-22 | Planned Option Sale | 800 | $65.18 | $52,144.00 | (3%) 23.07K to 22.27K | |
| 08-Feb-22 4:25 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Feb-22 | Option Exercise | 1,000 | $38.35 | $38,350.00 | 4% 22.27K to 23.27K | |
| 08-Feb-22 4:25 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Feb-22 | Planned Option Sale | 1,000 | $65.18 | $65,180.00 | (4%) 23.27K to 22.27K | |
| 25-Jan-22 4:36 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 21-Jan-22 | Option Exercise | 200 | $38.35 | $7,670.00 | < 1% 22.27K to 22.47K | |
| 25-Jan-22 4:36 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 21-Jan-22 | Planned Option Sale | 200 | $65.41 | $13,082.00 | (< 1%) 22.47K to 22.27K | |
| 20-Jan-22 7:24 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 19-Jan-22 | Option Exercise | 2,199 | $38.35 | $84,331.60 | 10% 22.27K to 24.47K | |
| 20-Jan-22 7:24 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 19-Jan-22 | Planned Option Sale | 2,199 | $65.51 | $144,056.00 | (9%) 24.47K to 22.27K | |
| 20-Jan-22 7:24 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 18-Jan-22 | Option Exercise | 23,440 | $45.30 | $1,061,940.00 | 105% 22.27K to 45.71K | |
| 20-Jan-22 7:24 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 18-Jan-22 | Planned Option Sale | 23,440 | $65.26 | $1,529,590.00 | (51%) 45.71K to 22.27K | |
| 11-Jun-21 8:38 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 10-Jun-21 | Market Sale (Planned) | 5,689 | $59.60 | $339,063.00 | (20%) 27.96K to 22.27K | |
| 11-Jun-21 8:38 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-21 | Grant | 7,000 | -- | -- | 33% 20.96K to 27.96K | |
| 08-Jun-21 4:20 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-21 | Market Sale | 3,930 | $61.04 | $239,875.00 | (16%) 24.89K to 20.96K | (1%) |
| 15-Apr-21 8:35 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Apr-21 | Option Exercise | 21,823 | $40.28 | $878,943.00 | 88% 24.89K to 46.71K | |
| 15-Apr-21 8:35 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Apr-21 | Market Option Sale (Planned) | 21,823 | $66.95 | $1,461,070.00 | (47%) 46.71K to 24.89K | |
| 17-Sep-20 7:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 17-Sep-20 | Option Exercise | 27,871 | $39.19 | $1,092,270.00 | 112% 24.89K to 52.76K | |
| 17-Sep-20 7:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 17-Sep-20 | Market Option Sale (Planned) | 27,871 | $59.82 | $1,667,290.00 | (53%) 52.76K to 24.89K | 1% |
| 17-Sep-20 7:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Sep-20 | Option Exercise | 27,853 | $39.19 | $1,091,560.00 | 112% 24.89K to 52.74K | |
| 17-Sep-20 7:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Sep-20 | Market Option Sale (Planned) | 27,853 | $60.14 | $1,675,150.00 | (53%) 52.74K to 24.89K | 2% |
| 17-Sep-20 7:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Sep-20 | Option Exercise | 27,853 | $39.19 | $1,091,560.00 | 112% 24.89K to 52.74K | |
| 17-Sep-20 7:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Sep-20 | Market Option Sale (Planned) | 27,853 | $59.39 | $1,654,060.00 | (53%) 52.74K to 24.89K | < 1% |
| 11-Jun-20 6:35 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-20 | Grant | 14,000 | -- | -- | 129% 10.89K to 24.89K | |
| 08-Jun-20 9:10 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-20 | Market Sale | 5,904 | $48.61 | $286,993.00 | (35%) 16.79K to 10.89K | (22%) |
| 08-Jun-20 9:10 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-20 | Market Sale | 2,402 | $46.33 | $111,287.00 | (13%) 19.19K to 16.79K | (28%) |
| 16-Aug-19 4:15 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 14-Aug-19 | Market Sale (Planned) | 6,252 | $39.49 | $246,891.00 | (25%) 25.45K to 19.19K | (50%) |
| 06-Jun-19 5:06 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-19 | Grant | 5,600 | -- | -- | 28% 19.84K to 25.45K | |
| 06-Jun-19 5:06 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-19 | Market Sale | 2,529 | $42.91 | $108,519.00 | (11%) 22.37K to 19.84K | (38%) |
| 16-Aug-18 5:12 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 14-Aug-18 | Market Sale (Planned) | 4,773 | $47.04 | $224,522.00 | (18%) 27.15K to 22.37K | (26%) |
| 15-Jun-18 7:21 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Jun-18 | Grant | 7,875 | -- | -- | 41% 19.27K to 27.15K | |
| 06-Jun-18 8:11 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-18 | Market Sale | 2,040 | $33.02 | $67,360.80 | (10%) 21.31K to 19.27K | (79%) |
| 20-Nov-17 6:44 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 17-Nov-17 | Option Exercise | 7,857 | $25.37 | $199,332.00 | 37% 21.31K to 29.17K | |
| 20-Nov-17 6:44 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 17-Nov-17 | Market Option Sale (Planned) | 7,857 | $40.00 | $314,280.00 | (27%) 29.17K to 21.31K | (48%) |
| 20-Nov-17 6:44 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Nov-17 | Option Exercise | 2,143 | $25.37 | $54,367.90 | 10% 21.31K to 23.45K | |
| 20-Nov-17 6:44 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Nov-17 | Market Option Sale (Planned) | 2,143 | $40.01 | $85,741.40 | (9%) 23.45K to 21.31K | (48%) |
| 17-Aug-17 6:56 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Aug-17 | Market Sale (Planned) | 3,461 | $36.75 | $127,192.00 | (14%) 24.77K to 21.31K | (61%) |
| 16-Jun-17 8:10 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 14-Jun-17 | Grant | 11,000 | -- | -- | 80% 13.77K to 24.77K | |
| 07-Jun-17 7:03 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-17 | Market Sale | 1,877 | $43.32 | $81,313.50 | (12%) 15.65K to 13.77K | (37%) |
| 17-May-17 6:45 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-May-17 | Option Exercise | 21,041 | $10.50 | $220,856.00 | 134% 15.65K to 36.69K |